ArticlebioRxiv : the preprint server for biology2026
Nephron-associated Support Cell Transcriptional Plasticity Expands in Hypertension.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hypertension (HTN) affects over one billion people worldwide and can lead to debilitating cardiovascular and renal conditions if left untreated. Cell death in the kidneys and the inflammation that follows are among the primary effects of chronically elevated blood pressure. There are several cell types throughout the body with immunomodulatory, anti-inflammatory, and pro-regenerative properties that support tissue homeostasis and recent studies have highlighted their therapeutic potential in HTN and kidney-related conditions. In our previous paper, we found a pool of multipotent nephron-associated support cells (SCs) in single-cell RNA sequencing samples of CD31+ and podoplanin+ cells taken from the kidneys of hypertensive mice generated through two mouse models of HTN. Despite remaining roughly constant in number between HTN and control groups, these SCs had 299 differentially expressed genes (p<0.01), 51 and 86 enriched pathways (p<0.01) in the M2 and M5 Molecular Signatures Database gene sets, respectively, and 180 HTN-specific regulons. We also compared lymphatic endothelial cells (LECs) and SCs from HTN and control groups and identified 3636 differentially expressed genes (p<0.01), 537 M2 and 415 M5 enriched pathways (p<0.01), and 218 LEC-specific and 227 SC-specific regulons in the HTN samples. SCs from mice with HTN were more resistant to inflammation-induced changes compared to LECs, and had downregulated stem cell suppressive genes and upregulated genes related to stem cell proliferation and regeneration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.